R

Response Oncology Inc
OTC:ROIX

Watchlist Manager
Response Oncology Inc
OTC:ROIX
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $12

Response Oncology Inc
Retained Earnings

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Response Oncology Inc
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
R
Response Oncology Inc
OTC:ROIX
Retained Earnings
-$121.1m
CAGR 3-Years
-33%
CAGR 5-Years
-26%
CAGR 10-Years
-11%
Universal Health Services Inc
NYSE:UHS
Retained Earnings
$7.2B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
5%
Tenet Healthcare Corp
NYSE:THC
Retained Earnings
$4.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
HCA Healthcare Inc
NYSE:HCA
Retained Earnings
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Surgery Partners Inc
NASDAQ:SGRY
Retained Earnings
-$815.2m
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
-10%
iRhythm Technologies Inc
NASDAQ:IRTC
Retained Earnings
-$803.4m
CAGR 3-Years
-15%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
No Stocks Found

Response Oncology Inc
Glance View

Market Cap
12 USD
Industry
N/A

Response Oncology, Inc. engages in the provision of cancer treatment services through outpatient facilities known as IMPACT centers. The company is headquartered in Memphis, Tennessee and currently employs 10 full-time employees. As of May 20, 2002, the Company had liquidated substantially all of its operating assets and anticipates that the remaining assets will be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, the Company provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the non-medical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.

ROIX Intrinsic Value
Not Available
R

See Also

What is Response Oncology Inc's Retained Earnings?
Retained Earnings
-121.1m USD

Based on the financial report for Mar 31, 2002, Response Oncology Inc's Retained Earnings amounts to -121.1m USD.

What is Response Oncology Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-11%

Over the last year, the Retained Earnings growth was -73%. The average annual Retained Earnings growth rates for Response Oncology Inc have been -33% over the past three years , -26% over the past five years , and -11% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett